**BREAKING: 'TRUMPRX' TRIAL DATA SHOCKS MEDICAL WORLD – PATIENTS REPORT 'REVERSE AGING' in CLINICAL TRIALS**

BREAKING: ‘TRUMPRX’ TRIAL DATA SHOCKS MEDICAL WORLD – PATIENTS REPORT ‘REVERSE AGING’ IN CLINICAL TRIALS

Washington, D.C. – In a development that has stunned the medical establishment and rekindled the national debate on longevity, leaked data from the TrumpRX trial consortium suggests that subjects following the personalized, “nutrigenomic” protocol have shown biomarkers associated with a 15-20 year reversal in biological aging over a 24-month period.

Doctors are calling it the “Resilience Effect.”

The program, quietly funded by a group of pro-longevity investors and developed by a former Trump administration health technology advisor, does not claim to be a drug. Instead, it combines ultra-personalized intermittent metabolic cycling with a precision peptide regime, all tracked via a proprietary AI wearable known as the “Patriot Pod.”

“We’re not curing diseases. We’re turning off the clock,” said Dr. Elena Vance, the lead researcher (and a former critic of the program), in a leaked internal memo. “We have multiple patients in their late 60s with cardiac, cognitive, and dermal readings indistinguishable from individuals in their late 40s. The immune system rejuvenation data is unprecedented.”

Critics are already mobilizing. The FDA has released a terse statement reminding the public that the protocol is not federally approved, and the American Medical Association warned of “unregulated biological gambling.” Social media is ablaze with #TrumpRX, with detractors calling it a “dangerous, unproven fad” and supporters hailing it as “the greatest health breakthrough since penicillin.”

The White House declined to comment, but a spokesperson for the former president issued a statement: “While this has nothing to do with any political campaign, it’s yet another example of American innovation being stifled by a broken system.”

With the data now peer-reviewed and set for publication next month